1. Deciphering Fc-effector functions against SARS-CoV-2.
- Author
-
Beaudoin-Bussières, Guillaume and Finzi, Andrés
- Subjects
- *
SARS-CoV-2 , *ANTIBODY-dependent cell cytotoxicity , *BREAKTHROUGH infections , *ANTIBODY formation , *VIRUS diseases - Abstract
Vaccination and infection elicit antibodies with Fc-effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). Fc-effector functions are more stable than neutralization in convalescent individuals. Hybrid immunity generates higher levels of Fc-effector functions than vaccination alone. Fc-effector functions play a protective role against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different animal models. Caution should be used when selecting assays to measure Fc-effector functions. Major efforts were deployed to study the antibody response against SARS-CoV-2. Antibodies neutralizing SARS-CoV-2 have been extensively studied in the context of infections, vaccinations, and breakthrough infections. Antibodies, however, are pleiotropic proteins that have many functions in addition to neutralization. These include Fc-effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and antibody-dependent cellular phagocytosis (ADCP). Although important to combat viral infections, these Fc-effector functions were less studied in the context of SARS-CoV-2 compared with binding and neutralization. This is partly due to the difficulty in developing reliable assays to measure Fc-effector functions compared to antibody binding and neutralization. Multiple assays have now been developed and can be used to measure different Fc-effector functions. Here, we review these assays and what is known regarding anti-SARS-CoV-2 Fc-effector functions. Overall, this review summarizes and updates our current state of knowledge regarding anti-SARS-CoV-2 Fc-effector functions. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF